- Home
- PLTR vs JNJ Comparison
PLTR vs JNJ Comparison
Compare PLTR & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTR
- JNJ
- Stock Information
- Founded
- PLTR 2003
- JNJ 1886
- Country
- PLTR United States
- JNJ United States
- Employees
- PLTR N/A
- JNJ 139800
- Industry
- PLTR Retail: Computer Software & Peripheral Equipment
- JNJ Biotechnology: Pharmaceutical Preparations
- Sector
- PLTR Technology
- JNJ Health Care
- Exchange
- PLTR Nasdaq
- JNJ Nasdaq
- Market Cap
- PLTR 364.9B
- JNJ 408.0B
- IPO Year
- PLTR 2020
- JNJ 1944
- Fundamental
- Price
- PLTR $158.80
- JNJ $168.35
- Analyst Decision
- PLTR Hold
- JNJ Buy
- Analyst Count
- PLTR 20
- JNJ 15
- Target Price
- PLTR $99.11
- JNJ $173.00
- AVG Volume (30 Days)
- PLTR 67.7M
- JNJ 8.6M
- Earning Date
- PLTR 08-04-2025
- JNJ 07-16-2025
- Dividend Yield
- PLTR N/A
- JNJ 3.09%
- EPS Growth
- PLTR 92.54
- JNJ N/A
- EPS
- PLTR 0.23
- JNJ 9.33
- Revenue
- PLTR $3,115,024,000.00
- JNJ $90,627,000,000.00
- Revenue This Year
- PLTR $38.89
- JNJ $3.99
- Revenue Next Year
- PLTR $28.59
- JNJ $4.17
- P/E Ratio
- PLTR $688.92
- JNJ $18.03
- Revenue Growth
- PLTR 33.45
- JNJ 4.68
- 52 Week Low
- PLTR $21.23
- JNJ $140.68
- 52 Week High
- PLTR $160.38
- JNJ $169.99
- Technical
- Relative Strength Index (RSI)
- PLTR 68.84
- JNJ 71.16
- Support Level
- PLTR $145.06
- JNJ $162.78
- Resistance Level
- PLTR $155.44
- JNJ $169.99
- Average True Range (ATR)
- PLTR 4.73
- JNJ 2.57
- MACD
- PLTR 0.70
- JNJ 1.16
- Stochastic Oscillator
- PLTR 93.54
- JNJ 89.61
About PLTR Palantir Technologies Inc.
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.